Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Evaluating the Safety and Feasibility of Prophylactic Third-Party Nk Cell Administration in High-Risk Aml Patients Post-Hsct
Hamid Farajifard
Hamid Farajifard

Assistant Professor of Medical Immunology

Imam Khomeini Hospital Complex

Pediatric Cell and Gene Therapy Research Center

Tehran University of Medical Sciences

All Documents
15. Congenital Neutropenia and Primary Immunodeficiency Diseases, Critical Reviews in Oncology/Hematology (2019)